Category: Pharmaceuticals
The Debate Is Over: Antidepressants DO Work Better Than Placebo
The idea that antidepressants are no more effective than placebo has been put to rest. They clearly work when used appropriately, although the effect size is not as large as the published studies have suggested.
The Elephant in the Compounding Pharmacy
Contaminated products from compounding pharmacies have harmed and even killed patients. Quality control measures are being implemented, but there is a bigger problem: the injudicious use of untested and potentially dangerous treatments.
Medical Marijuana: Where is the evidence?
Marijuana is widely touted as an effective medicine for an array of conditions. But what does the evidence actually tell us?
If you feel better, should you stop taking your antibiotics?
A recent paper suggests that patients would be better off stopping antibiotics when they feel better, instead of completing the entire amount prescribed. Could this approach reduce antibiotic overuse and the risk of widespread resistance?
The Movie “Cholesterol: The Great Bluff” Is an Exercise in Denialism
The movie "Cholesterol: The Great Bluff" claims that we have been lied to: cholesterol doesn't cause heart disease and statins are harmful. It is biased and misleading. The people interviewed in the movie are denialists who don't accept the clear evidence for the role of blood cholesterol levels and the benefits of statins.
“New vaccine replaces statins?” Not So Fast!
News reports suggest new drugs may replace statins. PSCK9 inhibitors are useful, but only along with statins in high risk patients not controlled on statins alone, or for patients who can't tolerate statins. They're not about to replace statins.
Are drug expiry dates really a myth?
Are drug expiry dates just an industry ploy to keep you buying new bottles of medicine?
Most Patients Get No Benefit from Most Drugs
Some people are reluctant to take statins because they don't benefit the majority of patients who take them. Actually, most drugs don't benefit most of the patients who take them. Since we have no way of identifying those who will benefit, we are stuck treating the many to benefit the few.
Sen. Ron Johnson: Holding the bill funding the FDA hostage unless the cruel sham that is right-to-try is added to it
Advocates claim that "right-to-try" laws help terminally patients by allowing them access to experimental drugs before approval, when, in fact, such laws strip legal and regulatory protections from patients using such drugs and their purpose is actually to undermine and weaken the FDA. Now advocates led by Sen. Ron Johnson (R-WI) are making a new push to pass right-to-try by embedding it...
A closer look at penicillin allergies
While many people believe they may be allergic to penicillin, few actually are. The consequences may be serious.